Tenax Therapeutics, Inc. announced the expansion of its Board of Directors with the appointment of Steven Boyd and Keith Maher, M.D. Both Directors are from Armistice Capital, LLC. Mr. Boyd has served since 2012 as the chief investment officer of Armistice Capital, LLC. Dr. Maher has served as a managing director at Armistice since 2019. Dr. Maher currently serves on the boards of directors of Tetraphase Pharmaceuticals Inc., EyeGate Pharmaceuticals, Inc. and Vaxart, Inc.